
Adjuvant nivolumab plus standard chemoradiotherapy ‘tremendous’ for locoregional HNSCC
Add topic to email alerts Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways: The addition of nivolumab to standard …